Green Hygienics Holdings Inc. (GRYN) Executes Agreement with Cinvestav, the Leading Mexican Academic Research Institution, to Advance Research Targeting Endocannabinoid System (ECS) Deficiencies
May 20, 2021 08:30 ET | Green Hygienics Holdings Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is pleased to announce it has entered into a...
Green Hygienics Holdings Inc. (GRYN) Executes Agreement with Cinvestav, the Leading Mexican Academic Research Institution, to Advance Research Targeting Endocannabinoid System (ECS) Deficiencies
May 20, 2021 08:30 ET | Green Hygienics Holdings Inc.
SAN DIEGO, May 20, 2021 (GLOBE NEWSWIRE) -- via InvestorWire -- Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company") is pleased to announce it has entered into a...
GRYN logo.jpg
Green Hygienics Holdings Inc. (GRYN) Launches TruLife Biotech, LLC. to Advance the Study of Hemp-derived Cannabinoid Therapeutics
May 04, 2021 09:00 ET | Green Hygienics Holdings Inc.
SAN DIEGO, May 04, 2021 (GLOBE NEWSWIRE) -- via InvestorWire – Green Hygienics Holdings Inc. (OTCQB: GRYN) ("Green Hygienics" or the "Company"), announces today that it will move forward with the...
logo.png
Corbus Pharmaceuticals to Present at Two Upcoming Investor Conferences
March 09, 2021 08:05 ET | Corbus Pharmaceuticals Holdings, Inc.
Norwood, MA, March 09, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the “Company”), a clinical-stage drug development company pioneering transformative...
logo.png
Corbus Pharmaceuticals to Report Fourth Quarter and Year-End 2020 Results on March 15, 2021
March 08, 2021 08:05 ET | Corbus Pharmaceuticals Holdings, Inc.
•   Company to host conference call and webcast on Monday, March 15, 2021 at 8:30 a.m. ET Norwood, MA, March 08, 2021 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP)...
logo.png
Corbus Pharmaceuticals Announces Presentations at the New York Academy of Sciences Webinar on Targeting the Endocannabinoid System to Treat Human Diseases
January 20, 2021 08:05 ET | Corbus Pharmaceuticals Holdings, Inc.
Presentations about compounds in Corbus’ pipeline will highlight mechanistic studies of lenabasum, a CB2 agonist, and preclinical data from CB2 agonist oncology program and CB1 inverse agonist...
logo.png
Corbus Pharmaceuticals to Present at the Jefferies Virtual London Healthcare Conference
November 12, 2020 08:05 ET | Corbus Pharmaceuticals Holdings, Inc.
Fireside chat with live audio webcast on Thursday, November 19th at 12:35 PM EST Norwood, MA, Nov. 12, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or the...
logo.png
Corbus Pharmaceuticals to Report Third Quarter Results on November 10, 2020
November 03, 2020 08:05 ET | Corbus Pharmaceuticals Holdings, Inc.
Company to host conference call and webcast on Tuesday, November 10 at 8:30 a.m. ET Norwood, MA, Nov. 03, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus”...
logo.png
Corbus Pharmaceuticals to Report First Quarter Results on May 11, 2020
May 04, 2020 08:05 ET | Corbus Pharmaceuticals Holdings, Inc.
- Management to host conference call and webcast on Monday, May 11 at 8:30 a.m. ET- NORWOOD, MA, May 04, 2020 (GLOBE NEWSWIRE) -- Corbus Pharmaceuticals Holdings, Inc. (NASDAQ: CRBP) (“Corbus” or...
logo.png
Corbus Announces Publication of Lenabasum Systemic Sclerosis Double-Blind, Placebo-Control Phase 2 Clinical Trial Results in Arthritis & Rheumatology
April 29, 2020 08:05 ET | Corbus Pharmaceuticals Holdings, Inc.
These previously presented data demonstrated lenabasum improved efficacy outcomes and underlying disease pathology compared to placebo and had an acceptable safety profile in Phase 2 studySystemic...